Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000104

Drug Information
NameTrazodone    
SynonymsTrittico (TN); KBio2_001904; Desyrel Dividose; KBio3_002540; 19794-93-5; CHEMBL621; Lopac-T-6154; Trazodonum; DB00656; Trazodona [INN-Spanish]; LS-156735; Trazodona; NCGC00016035-09; 1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-; Desyrel(trazodone hcl salt); CAS-25332-39-2; Lopac0_001159; Prestwick2_000292; 2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one; EINECS 243-317-1; Trazodonum [Latin]; Oprea1_185901; Prestwick1_000292; CID5533; Trazodonum [INN-Latin]; Trazodone [INN:BAN]; BSPBio_000224; NINDS_000196; L000771; nchembio873-comp51; UNII-YBK48BXK30; Trazalon; trazodone (Desyrel); NCGC00016035-01; IDI1_000196; MLS000758230; Trazolan; BRD-K70778732-003-05-1; 1,2,4-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-; Trazodon; Trazodone Hcl; AC-6778; 2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one; KBioGR_001110; Spectrum4_000755; KBio2_007040; Spectrum2_000854; NCGC00024405-03; BPBio1_000248; Spectrum5_000974; AC1L1KK2; Desirel; Prestwick3_000292; Trazodil; Trazodone (INN); Sideril; 8-[3-[4-(3-Chlorophenyl)piperazin-1-yl]propyl]-1,7,8-triazabicyclo[4.3.0]nona-2,4,6-trien-9-one hydrochloride; Trittico; I06-1977; Tradozone; BSPBio_003040; Beneficat; Trazodona [Spanish]; s-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(4-(m-chlorophenyl)-1-piperazinyl)propyl)-; C07156; SPBio_002443; NCGC00016035-03; BRN 0628010; KBio1_000196; CHEBI:9654; 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one; C19H22ClN5O; SPBio_000867; D08626; Trialodine; Trazonil; Spectrum3_001560; trazodone; Spectrum_001424; NCGC00016035-02; KBio2_004472; MolPort-003-850-601; DivK1c_000196; Prestwick0_000292; KBioSS_001904    
Trade NameDesyrel; Beneficat; Deprax; Desirel; Molipaxin; Thombran; Trazorel; Trialodine; Trittico    
CompanyAngelini research laboratories    
IndicationDepressionApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntidepressive Agents    
CAS NumberCAS 19794-93-5
FormularC19H22ClN5O    
PubChem Compound IDCID 5533.    
PubChem Substance IDSID 9365.    
ChEBI9654;    
SuperDrug ATC IDN06AX05;    
SuperDrug CAS ID019794935;    
TargetNorepinephrine reuptakeInhibitor[2][3]
Norepinephrine reuptakeMultitarget[2][3]
Serotonin reuptakeInhibitor[2][3]
Serotonin reuptakeMultitarget[2][3]
Ref 1Emerging treatments for depression. Expert Opin Pharmacother. 2006 Dec;7(17):2323-39. To Reference
Ref 2Clinically relevant drug interactions with new generation antidepressants and antipsychotics. Ther Umsch. 2009 Jun;66(6):485-92. To Reference
Ref 3Curr Top Med Chem. 2006;6(17):1801-23.Serotonin reuptake inhibitors: the corner stone in treatment of depression for half a century--a medicinal chemistry survey. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543